Pharma Pulse 8/21/24: Choosing the Best Clinical Technology for Your Study, Walmart Launches Autoimmune-Focused Specialty Pharmacies of the Community & more

News
Article

The latest news for pharma industry insiders.

Choosing the Best Clinical Technology for Your Study

In part three of this video interview, Melissa Easy, VP commercial, digital products & solutions, IQVIA touches on how the right technology for your study should alleviate site burden and improve data quality.

Walmart Launches Autoimmune-Focused Specialty Pharmacies of the Community

In an interview with Pharmacy Times, Aleata Postell, group director of pharmacy business development and head of specialty pharmacy at Walmart, discussed the new autoimmune-focused specialty pharmacies of the community (SPOCs). Postell said these pharmacies bring high-touch specialty pharmacies into local communities for patients with more complex needs.

A $3 Million Gene-Therapy Maker at a Bargain Price

Sarepta’s treatment for Duchenne muscular dystrophy should become a blockbuster next year.

Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets

The agreement builds on Organon’s global product portfolio for conditions that impact women disproportionately. Women are three times more likely to experience migraine than men.

ACG World on LinkedIn

At ACG, we believe that establishing long-term sustainability goals is essential for securing a resilient future. Through our strategic partnerships and dedicated focus on decarbonization, we're making significant strides in reducing carbon emissions and championing sustainable practices. Together, we can build a greener, more sustainable world. I invite you to explore more about our journey and vision in an article by our CEO of Packaging Materials,Shivshankar S.R. - https://lnkd.in/dAmxqMhJ

#Sustainability #NetZero #CorporateResponsibility #GreenManufacturing #Innovation #MakeItBetter Pharmaceutical Commerce Magazine

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs

© 2024 MJH Life Sciences

All rights reserved.